个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Influence of Eastern Cooperative Oncology Group performance status (ECOG PS), tumor size and age on patient outcomes after anlotinib treatment: A subgroup analysis based on ALTER01031 trial for medullary thyroid carcinoma (MTC).

| 认领 | 导出 |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：
Gao, Ming[1] ; Chi, Yihebali[2,3] ; Zheng, Xiangqian[1] ; Li, Dapeng[1] ; Tang, Pingzhang[2,3] ; Xu, Zhengang[2,3] ; Chen, Xiaohong[4] ; Ge, Minghua[5] ; Zhang, Yuan[6] ; Guo, Zhuming[7] ; Wang, Jun[8] ; Chen, Jie[9] ; Zhang, Jiewu[10] ; Cheng, Ying[11] ; Li, Zhendong[12] ; Liu, Hui[13] ; Qin, Jianwu[14,15] ; Zhu, Jingqiang[16] ; Cheng, Ruochuan[17] ;
机构： [1]Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China [2]Chinese Acad Med Sci, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China [3]Peking Union Med Coll, Beijing, Peoples R China [4]Capital Med Univ, Beijing Tongren Hosp, Beijing, Peoples R China [5]Univ Chinese Acad Sci, Zhejiang Canc Hosp, Zhejiang Prov Peoples Hosp,Chinese Acad Sci,Canc, Peoples Hosp,Hangzhou Med Coll,Inst Canc & Basic, Hangzhou, Peoples R China [6]Nanjing Med Univ, Affiliated Canc Hosp, Jiangsu Canc Hosp, Jiangsu Inst Canc Res, Nanjing, Peoples R China [7]Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China [8]Gansu Prov Canc Hosp, Lanzhou, Peoples R China [9]Hunan Canc Hosp, Changsha, Peoples R China [10]Harbin Med Univ, Canc Hosp, Harbin, Peoples R China [11]Jilin Canc Hosp, Changchun, Peoples R China [12]China Med Univ, Liaoning Tumor Hosp & Inst, Tumor Hosp, Shenyang, Peoples R China [13]Fujian Canc Hosp, Fuzhou, Peoples R China [14]Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Peoples R China [15]Henan Canc Hosp, Zhengzhou, Peoples R China [16]Sichuan Univ, West China Hosp, Chengdu, Peoples R China [17]Kunming Med Univ, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China
出处：
ISSN：
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2021]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
最新[2023]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
JCR分区：
出版当年[2020]版：
Q1 ONCOLOGY
最新[2023]版：
Q1 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者：
第一作者机构： [1]Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China
推荐引用方式(GB/T 7714)：
Gao Ming,Chi Yihebali,Zheng Xiangqian,et al.Influence of Eastern Cooperative Oncology Group performance status (ECOG PS), tumor size and age on patient outcomes after anlotinib treatment: A subgroup analysis based on ALTER01031 trial for medullary thyroid carcinoma (MTC).[J].JOURNAL OF CLINICAL ONCOLOGY.2020,38(15):
APA：
Gao, Ming,Chi, Yihebali,Zheng, Xiangqian,Li, Dapeng,Tang, Pingzhang...&Cheng, Ruochuan.(2020).Influence of Eastern Cooperative Oncology Group performance status (ECOG PS), tumor size and age on patient outcomes after anlotinib treatment: A subgroup analysis based on ALTER01031 trial for medullary thyroid carcinoma (MTC)..JOURNAL OF CLINICAL ONCOLOGY,38,(15)
MLA：
Gao, Ming,et al."Influence of Eastern Cooperative Oncology Group performance status (ECOG PS), tumor size and age on patient outcomes after anlotinib treatment: A subgroup analysis based on ALTER01031 trial for medullary thyroid carcinoma (MTC).".JOURNAL OF CLINICAL ONCOLOGY 38..15(2020)

资源点击量：53661 今日访问量：0 总访问量：1665 更新日期：2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持：重庆聚合科技有限公司 地址：云南省昆明市西昌路295号(650032)